rebel Financial rebel Financial
← All Posts
ETON

Eton Pharmaceuticals, Inc.

June 10, 2026 • Author: Phil Ratcliff • ETON
Item Proposal Vote
1.01 To elect Jenn Adams as Class II director to hold office until the 2029 annual meeting of stockholders and until a successor is duly elected and qualified, or until earlier resignation or removal. ✓ For
1.02 To elect Charles J. Casamento as Class II director to hold office until the 2029 annual meeting of stockholders and until a successor is duly elected and qualified, or until earlier resignation or removal. ✓ For
2 To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. ✓ For
Attachments
📄
ETON_ANNUAL_REPORT_2025.pdf 0.9 MB
📄
ETON_PROXY_STATEMENT.pdf 0.3 MB
This article was written for information purposes only and its content should not be construed by any consumer and/or prospective client as rebel Financial's solicitation to affect, or attempt to affect transactions in securities, or the rendering of personalized investment advice for compensation. No client or prospective client should assume that any such discussion serves as the receipt of, or a substitute for, personalized advice from rebel Financial, or from any other investment professional. See our disclosures page for more information.